Bevacizumab (BEV) + Chemotherapy (CT) Beyond First Progression in Patients (PTS) with Metastatic Colorectal Cancer (MCRC) Previously Treated with First-Line BEV + CT (ML18147): Efficacy and Safety Analyses by Oxaliplatin vs Irinotecan-Based CT | Publicación